MDMA’s 2018 FDA Forum continues to grow as the conference to engage with leading policy makers and experts. This popular two day seminar focuses on unique insights and strategies to navigate the 510(k) and PMA regulatory pathways.
Confirmed FDA Speakers Include:
William Maisel, Deputy Center Director for Science & Chief Scientist, CDRH, FDA
Sean Boyd, Deputy Director for Regulatory Affairs, Office of Compliance, FDA
Abiy Desta, Ombudsman, CDRH, FDA (via video conferencing)
Elizabeth Hillebrenner, Associate Director for Programs and Performance, Office of In Vitro Diagnostics and Radiological Health, CDRH, FDA
Joshua Nipper, Chief of Premarket Approval Staff, Office of Device Evaluation, CDRH, FDA
Bakul Patel, Associate Director for Digital Health, Office of the Center Director, CDRH, FDA
Marjorie Shulman, Chief of Premarket Notification (510(k)) Section, Office of Device Evaluation, CDRH, FDA
Suzanne Schwartz, MD, MBA, Associate Director for Science and Strategic Partners hips, Office of the Center Director, CDRH, FDA